Healthpeak Properties (NYSE:DOC) Given New $24.00 Price Target at Wedbush

Healthpeak Properties (NYSE:DOC - Free Report) had its price objective cut by Wedbush from $27.00 to $24.00 in a research note released on Friday,Benzinga reports. They currently have an outperform rating on the real estate investment trust's stock. Wedbush also issued estimates for Healthpeak Properties' FY2025 earnings at $1.85 EPS and FY2026 earnings at $1.96 EPS.

Other equities research analysts have also recently issued reports about the company. StockNews.com cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday, October 30th. Royal Bank of Canada upped their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. Wells Fargo & Company cut their target price on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 10th. Robert W. Baird cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Finally, Mizuho cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $24.00.

Healthpeak Properties Price Performance

Shares of DOC stock traded up $0.01 during trading on Friday, hitting $19.60. The company had a trading volume of 3,483,730 shares, compared to its average volume of 4,795,343. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.31 and a current ratio of 1.35. The firm has a market capitalization of $13.71 billion, a P/E ratio of 55.99, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15. The stock's 50-day moving average price is $20.32 and its 200 day moving average price is $21.44. Healthpeak Properties has a one year low of $16.01 and a one year high of $23.26.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 6.23%. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 14th. Healthpeak Properties's dividend payout ratio is presently 342.87%.

Institutional Trading of Healthpeak Properties

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp acquired a new stake in Healthpeak Properties in the third quarter valued at $1,093,576,000. JPMorgan Chase & Co. grew its holdings in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after acquiring an additional 4,056,931 shares during the period. Geode Capital Management LLC grew its holdings in Healthpeak Properties by 3.6% during the 4th quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust's stock worth $371,168,000 after acquiring an additional 638,012 shares during the period. Principal Financial Group Inc. grew its holdings in Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the period. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in Healthpeak Properties by 10.6% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust's stock worth $350,021,000 after acquiring an additional 1,651,235 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.